N-(+)-Biotinyl-6-aminohexanoic acid
Need Assistance?
  • US & Canada:
    +
  • UK: +

N-(+)-Biotinyl-6-aminohexanoic acid

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

N-(+)-Biotinyl-6-aminohexanoic acid may be used in the biosynthesis of biotinylated oligosaccharides. Biotinyl-6-aminohexanoic acid is frequently used as a derivative of N-hydroxysuccinimide ester.

Category
D-Amino Acids
Catalog number
BAT-001607
CAS number
72040-64-3
Molecular Formula
C16H27N3O4S
Molecular Weight
357.47
N-(+)-Biotinyl-6-aminohexanoic acid
IUPAC Name
6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoic acid
Synonyms
N-Biotinylcaproic Acid; 6-[[5-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]hexanoic Acid; 6-[(Biotinyl)amino]hexanoic acid; Biotin X; (+)-Biotin-epsilon-aminocaproic acid; E-AMINO BIOTINYL CAPROIC ACID; biotin caproic acid; N-Biotinyl-6-aminohexanoic Acid; (+)-Biotin-LC; 6-(Biotinylamino)caproic acid; SCHEMBL383254; N-(5-Carboxypentyl)biotinamide; Biotinyl-6-aminohexanoic acid
Appearance
White to off-white crystalline powder
Purity
≥ 98 % (HPLC)
Density
1.200±0.06 g/cm3 (Predicted)
Melting Point
220-230 ℃ (dec.)
Boiling Point
721.3±55.0 ℃ (Predicted)
Storage
-20 ℃ under inert atmosphere
Solubility
Slightly soluble in DMSO
InChI
InChI=1S/C16H27N3O4S/c20-13(17-9-5-1-2-8-14(21)22)7-4-3-6-12-15-11(10-24-12)18-16(23)19-15/h11-12,15H,1-10H2,(H,17,20)(H,21,22)(H2,18,19,23)/t11-,12-,15-/m0/s1
InChI Key
CMUGHZFPFWNUQT-HUBLWGQQSA-N
Canonical SMILES
C1C2C(C(S1)CCCCC(=O)NCCCCCC(=O)O)NC(=O)N2
1. Chemoenzymatic synthesis of glycopolypeptides carrying alpha-Neu5Ac-(2-->3)-beta-D-Gal-(1-->3)-alpha-D-GalNAc, beta-D-Gal-(1-->3)-alpha-D-GalNAc, and related compounds and analysis of their specific interactions with lectins
X Zeng, Y Nakaaki, T Murata, T Usui Arch Biochem Biophys. 2000 Nov 1;383(1):28-37. doi: 10.1006/abbi.2000.2033.
Glycopolypeptide (1) carrying the beta-D-Gal-(1-->3)-alpha-D-GalNAc unit as a kind model of asialo-type mucin was synthesized through three steps: enzymatic synthesis of p-nitrophenyl disaccharide glycoside, reduction of the p-nitrophenyl group, and coupling of the amino group with the carboxyl group of poly(L-glutamic acid)s (PGA). In a similar manner, glycopolypeptides (2-7) carrying beta-D-Gal-(1-->3)-beta-D-GalNAc, beta-D-Gal-(1-->3)-beta-D-GlcNAc, beta-D-Gal-(1-->6)-alpha-D-GalNAc, beta-D-Gal-(1-->6)-beta-D-GalNAc, alpha-D-GalNAc, and beta-D-GalNAc, respectively, were synthesized as analogous polymers of polymer 1. Glycopolypeptides 8 and 9 as a mimic of sialo-type mucin were further prepared from polymers 1 and 2 as the acceptor of CMP-Neu5Ac by alpha2,3-(O)-sialyltransferase, respectively. Interactions of these glycopolypeptides with lectins were investigated with the double-diffusion test and the hemagglutination-inhibition assay and in terms of an optical biosensor based on surface plasmon resonance. Polymers 1 and 2 reacted strongly with peanut (Arachis hypogaea) agglutinin (PNA) and Agaricus bisporus agglutinin (ABA). On the other hand, polymers 8 and 9 through sialylation from polymers 1 and 2 reacted with ABA, but did not with PNA. Other polymers 3-7 did not show any reactivity for both the lectins. These results show that PNA acts precisely in an exo manner on the beta-D-Gal-(1-->3)-D-GalNAc sequence, while ABA acts in an endo manner. Polymers 6 and 7 substituted with GalNAc reacted strongly with soybean (Glycine max) agglutinin and Vicia villosa agglutinin B4, regardless of the configuration of the glycosidic linkage. The interaction of all polymers with Bauhinia purpurea agglutinin was much stronger than that of the corresponding sugars. Polymers 8 and 9 reacted with wheat germ (Triticum vulgaris) agglutinin (WGA), to which Neu5Ac residues are needed for binding, but polymers 1 and 2 did not. These sugar-substituted glycopolypeptides interacted specifically with the corresponding lectins. Furthermore, polymers 4-7 reacted with WGA, but the corresponding sugars did not. It suggests that the N-acetyl group along the PGA backbone has a cluster effect for WGA. The artificial glycopolypeptides were shown to be useful as tools and probes of carbohydrate recognition and modeling in the analysis of glycoprotein-lectin interactions.
2. Synthesis of mucin O-glycan core structures as their p-nitro- and p-aminophenyl glycosides
Martin Hollinger, Fana Abraha, Stefan Oscarson Carbohydr Res. 2011 Sep 6;346(12):1454-66. doi: 10.1016/j.carres.2011.03.036. Epub 2011 Apr 1.
For the investigation of glycosidases, and for the construction of glycan arrays the p-nitrophenyl- and p-aminophenyl glycosides of mucin O-glycan core structures 1-7 and the 2,6-ST-antigen have been chemically synthesized using d-galactose as a precursor for GalNAc residues. GlcNAc residues have partly been introduced using a 4,6-di-O-benzoyl-2,3-N,O-oxazolidinone-protected donor, which allowed deprotection of the formed di- and tri-saccharides in one step using sodium methoxide.
3. Convenient enzymatic synthesis of a p-nitrophenyl oligosaccharide series of sialyl N-acetyllactosamine, sialyl Le x and relevant compounds
Xiaoxiong Zeng, Hirotaka Uzawa Carbohydr Res. 2005 Nov 21;340(16):2469-75. doi: 10.1016/j.carres.2005.08.019. Epub 2005 Oct 5.
From the beta-D-Gal-(1-->4)-beta-D-GlcNAc-OC6H4NO2-p (1) prepared by the transglycosylation of beta-galactosidase from Bacillus circulans, alpha-D-Neu5Ac-(2-->3)-beta-D-Gal-(1-->4)-beta-D-GlcNAc-OC6H4NO2-p (9) and alpha-D-Neu5Ac-(2-->6)-beta-D-Gal-(1-->4)-beta-D-GlcNAc-OC6H4NO2-p (10) were effectively synthesized with an equimolar ratio of CMP-Neu5Ac by recombinant rat alpha-(2-->3)-N-sialyltransferase and rat liver alpha-(2-->6)-N-sialyltransferase, respectively. The former enzyme also transferred effectively the Neu5Ac residue from CMP-Neu5Ac to the location of OH-3 in the non-reducing terminal of beta-D-Gal-(1-->4)-beta-D-Gal-OC6H4NO2-p or beta-D-Gal-(1-->4)-beta-D-Gal-(1-->4)-beta-D-GlcNAc-OC6H4NO2-p, while the latter enzyme did not. In the case of equimolar ratio of GDP-Fuc/acceptor, 1 and 9 were further fucosylated quantitatively to form beta-D-Gal-(1-->4)-beta-D-(alpha-l-Fuc-(1-->3)-)-GlcNAc-OC6H4NO2-p (14) and alpha-D-Neu5Ac-(2-->3)-beta-D-Gal-(1-->4)-beta-D-(alpha-l-Fuc-(1-->3)-)-GlcNAc-OC6H4NO2-p (13) by recombinant human alpha-(1-->3)-fucosyltransferase VII, respectively.
Online Inquiry
Verification code
Inquiry Basket